Adam Simpson - Icosavax CEO and President
| ICVXDelisted Stock | USD 9.02 0.12 1.31% |
Insider
Adam Simpson is CEO and President of Icosavax
| Age | 48 |
| Phone | 206 737 0085 |
| Web | https://icosavax.com |
Adam Simpson Latest Insider Activity
Tracking and analyzing the buying and selling activities of Adam Simpson against Icosavax stock is an integral part of due diligence when investing in Icosavax. Adam Simpson insider activity provides valuable insight into whether Icosavax is net buyers or sellers over its current business cycle. Note, Icosavax insiders must abide by specific rules, including filing SEC forms every time they buy or sell Icosavax'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Adam Simpson over six months ago Bona fide gift to Adam Simpson of 6532 shares of Icosavax subject to Section 16 | ||
Adam Simpson over a year ago Exercise or conversion by Adam Simpson of 4789 shares of Icosavax subject to Rule 16b-3 | ||
Adam Simpson over a year ago Exercise or conversion by Adam Simpson of 15000 shares of Icosavax subject to Rule 16b-3 | ||
Adam Simpson over a year ago Sale by Adam Simpson of 62205 shares of Icosavax |
Icosavax Management Efficiency
The company has return on total asset (ROA) of (0.2673) % which means that it has lost $0.2673 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4223) %, meaning that it created substantial loss on money invested by shareholders. Icosavax's management efficiency ratios could be used to measure how well Icosavax manages its routine affairs as well as how well it operates its assets and liabilities.Icosavax currently holds 8.79 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Icosavax has a current ratio of 20.47, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Icosavax's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Prof MD | Hookipa Pharma | 81 | |
| Todd MD | Hepion Pharmaceuticals | 55 | |
| Marine Popoff | Hookipa Pharma | N/A | |
| Demetrios MD | Inozyme Pharma | N/A | |
| Jackie Parkin | Mereo BioPharma Group | 67 | |
| Mark Vignola | Terns Pharmaceuticals | 47 | |
| James MBA | Amylyx Pharmaceuticals | 58 | |
| Reinhard Kandera | Hookipa Pharma | 55 | |
| Gabriel BA | Immix Biopharma | 38 | |
| Tom Holmes | Amylyx Pharmaceuticals | N/A | |
| Daren Ure | Hepion Pharmaceuticals | N/A | |
| Mike Preigh | Day One Biopharmaceuticals | N/A | |
| Russell MS | Acumen Pharmaceuticals | 67 | |
| Alexandra HughesWilson | Mereo BioPharma Group | 54 | |
| JD MBA | Immix Biopharma | N/A | |
| Kerry MD | Terns Pharmaceuticals | N/A | |
| Janice Hitchcock | Acumen Pharmaceuticals | N/A | |
| Jaa Roberson | Day One Biopharmaceuticals | N/A | |
| Stephen MD | Hepion Pharmaceuticals | N/A | |
| Sharen Pyatetskaya | Hepion Pharmaceuticals | ||
| Eric MD | Acumen Pharmaceuticals | 69 | |
Management Performance
| Return On Equity | -0.42 | |||
| Return On Asset | -0.27 |
Icosavax Leadership Team
Elected by the shareholders, the Icosavax's board of directors comprises two types of representatives: Icosavax inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Icosavax. The board's role is to monitor Icosavax's management team and ensure that shareholders' interests are well served. Icosavax's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Icosavax's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Elizabeth Bekiroglu, General Secretary | ||
| Neil King, Chair CoFounder | ||
| Jennifer Raymond, Senior Operations | ||
| Ami MPH, Senior Affairs | ||
| Mr MPH, Chief Officer | ||
| Niranjan MD, Chief Officer | ||
| Cassia Cearley, Treasurer Officer | ||
| Charles Richardson, VP Operations | ||
| Thomas CFA, Chief Officer | ||
| Lori Stewart, Senior Culture | ||
| Adam Simpson, CEO and President | ||
| David Baker, Cofounder Board | ||
| David MD, Cofounder Board |
Icosavax Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Icosavax a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.42 | |||
| Return On Asset | -0.27 | |||
| Current Valuation | 547.9 M | |||
| Shares Outstanding | 50.23 M | |||
| Shares Owned By Insiders | 3.47 % | |||
| Shares Owned By Institutions | 87.64 % | |||
| Number Of Shares Shorted | 321.31 K | |||
| Price To Earning | 63.56 X | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 153.31 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |